---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-356869"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2021-12-14T23:59:59+00:00"
generated_at: "2026-06-28T01:08:34.160228+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Acadia names Mark Schneyer permanent CFO; previously interim CFO since Sept 2021

## Summary
- Mark Schneyer appointed EVP, CFO effective Dec 9, 2021; had served as interim CFO since Sept 2021.
- Schneyer previously SVP, Business Development and CBO; joined Acadia from Pfizer in May 2020.
- He led the Dec 2020 acquisition of CerSci Therapeutics, adding a Phase 2-ready pain program.
- Schneyer retains responsibility for business development and investor relations; reports to CEO Steve Davis.

## SEC filing metadata
- accession: 0001193125-21-356869
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2021-12-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312521356869/0001193125-21-356869-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312521356869/d246164d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-356869
- JSON: https://secwatch.observer/filing/0001193125-21-356869.json
- Plain text: https://secwatch.observer/filing/0001193125-21-356869.txt

## Key facts
- Executive change
  Mark C. Schneyer was appointed as Executive Vice President, Chief Financial Officer at ACADIA PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Executive Vice President, Chief Financial Officer
  source text: On December 9, 2021, the Board of Directors of Acadia Pharmaceuticals Inc. (the “Company”) appointed Mark C. Schneyer as Executive Vice President, Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1070494/000119312521356869/0001193125-21-356869-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
